Literature DB >> 18461296

[Interdisciplinary stratification of patients with myoma-related symptoms].

M David1.   

Abstract

With the establishment of uterine artery embolization (UAE), the individualization of treatment of the symptomatic myomatous uterus showed a general progression. The concrete therapy decision is made in an interactive process between doctor and patient. A series of factors influence the choice of a suitable, operative or non-operative, therapeutic procedure. In the weighting of therapeutic options between surgery or UAE, in addition to current results of studies which compare both techniques,recommendations made by expert committees and guidelines are helpful for a competent counseling of patients and additionally supportive in decision processes such as interdisciplinary stratification.

Entities:  

Mesh:

Year:  2008        PMID: 18461296     DOI: 10.1007/s00117-008-1682-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  18 in total

Review 1.  Controversies and challenges in the modern management of uterine fibroids.

Authors:  Isaac Manyonda; Eeson Sinthamoney; Anna-Maria Belli
Journal:  BJOG       Date:  2004-02       Impact factor: 6.531

2.  Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment--a prospective, randomized, and controlled clinical trial.

Authors:  Isabel Pinto; Paloma Chimeno; Alicia Romo; Laura Paúl; Javier Haya; Miguel A de la Cal; José Bajo
Journal:  Radiology       Date:  2003-02       Impact factor: 11.105

3.  Uterine-artery embolization versus surgery for symptomatic uterine fibroids.

Authors:  Richard D Edwards; Jonathan G Moss; Mary Ann Lumsden; Olivia Wu; Lilian S Murray; Sara Twaddle; Gordon D Murray
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

4.  Treatment of preterm infants at the lower margin of viability--a comparison of guidelines in German speaking countries.

Authors:  Roland Hentschel; Stella Reiter-Theil
Journal:  Dtsch Arztebl Int       Date:  2008-01-18       Impact factor: 5.594

5.  Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial.

Authors:  Michal Mara; Zuzana Fucikova; Jana Maskova; David Kuzel; Lucia Haakova
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-11-15       Impact factor: 2.435

6.  Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial.

Authors:  Wouter J K Hehenkamp; Nicole A Volkers; Peter F J Donderwinkel; Sjoerd de Blok; Erwin Birnie; Willem M Ankum; Jim A Reekers
Journal:  Am J Obstet Gynecol       Date:  2005-11       Impact factor: 8.661

7.  Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata.

Authors:  David M Hovsepian; Gary P Siskin; Joseph Bonn; John F Cardella; Timothy W I Clark; Leo E Lampmann; Donald L Miller; Reed A Omary; Jean-Pierre Pelage; Dheeraj Rajan; Marc S Schwartzberg; Richard B Towbin; Woodruff J Walker; David Sacks
Journal:  Cardiovasc Intervent Radiol       Date:  2004-06-23       Impact factor: 2.740

8.  A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy.

Authors:  S Dutton; A Hirst; K McPherson; T Nicholson; M Maresh
Journal:  BJOG       Date:  2007-11       Impact factor: 6.531

9.  Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy--results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial.

Authors:  Wouter J K Hehenkamp; Nicole A Volkers; Erwin Birnie; Jim A Reekers; Willem M Ankum
Journal:  Radiology       Date:  2008-01-09       Impact factor: 11.105

10.  Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial.

Authors:  Nicole A Volkers; Wouter J K Hehenkamp; Erwin Birnie; Willem M Ankum; Jim A Reekers
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.